Bioengineered

Scope & Guideline

Advancing Interdisciplinary Discoveries in Bioengineering

Introduction

Welcome to your portal for understanding Bioengineered, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2165-5979
PublisherTAYLOR & FRANCIS INC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2012 to 2024
AbbreviationBIOENGINEERED / Bioengineered
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'Bioengineered' focuses on publishing original research articles that explore the intersection of biology, engineering, and technology in the context of healthcare and environmental applications. Its primary aim is to disseminate knowledge and advancements in bioengineering that contribute to disease understanding, treatment, and innovative biotechnological solutions.
  1. Cancer Biology and Therapeutics:
    The journal emphasizes studies related to cancer mechanisms, including the roles of non-coding RNAs, signaling pathways, and therapeutic targets in various cancer types.
  2. MicroRNA and Long Non-Coding RNA Research:
    A significant portion of the research is dedicated to exploring the functions and mechanisms of microRNAs and long non-coding RNAs in regulating gene expression and their implications in diseases.
  3. Stem Cell and Regenerative Medicine:
    The journal covers advancements in stem cell research, including their applications in regenerative medicine and tissue engineering.
  4. Environmental Biotechnology:
    Research focusing on microbial applications for waste management, bioremediation, and biofuel production is also a core area, highlighting innovative uses of biotechnology in environmental sustainability.
  5. Drug Development and Pharmacology:
    The journal publishes studies related to drug design, development, and pharmacological evaluations of various compounds, particularly in the context of cancer and chronic diseases.
The journal 'Bioengineered' has been witnessing emerging trends that reflect the evolving landscape of bioengineering research. These trends indicate areas of increasing interest and innovation, showcasing the journal's commitment to publishing cutting-edge studies.
  1. Circular RNAs and Their Role in Disease:
    Recent publications highlight the increasing recognition of circular RNAs as significant regulatory molecules in various diseases, particularly in cancer, with research focusing on their role as biomarkers and therapeutic targets.
  2. Microbiome Research:
    There is a growing trend in studies investigating the gut microbiome and its impact on health, disease progression, and therapeutic responses, reflecting a broader interest in the microbiome's role in human health.
  3. Nanotechnology Applications in Medicine:
    Research involving the use of nanotechnology for drug delivery systems, imaging, and cancer therapy is gaining momentum, showcasing innovative approaches to enhance therapeutic efficacy and reduce side effects.
  4. CRISPR and Gene Editing Technologies:
    The journal is increasingly publishing studies that utilize CRISPR and other gene editing technologies, indicating a trend towards genetic interventions as pivotal tools in both research and therapeutic contexts.
  5. Immunotherapy and Cancer Treatment:
    There is an emerging focus on immunotherapy, particularly in the context of cancer treatment, with studies exploring various immunotherapeutic strategies and their mechanisms of action.

Declining or Waning

While 'Bioengineered' has maintained a strong focus on various aspects of bioengineering, certain research themes appear to be waning or declining in prominence. This could be attributed to shifting research interests or advancements in specific areas that have led to a reduction in related submissions.
  1. Traditional Pharmacology:
    There has been a noticeable decrease in studies focused solely on traditional pharmacological approaches without integration of bioengineering techniques, reflecting a shift towards more innovative and interdisciplinary research.
  2. Basic Biological Mechanisms:
    Research articles that purely focus on basic biological mechanisms without practical applications or engineering aspects seem to be less frequent, as the journal increasingly favors studies with translational implications.
  3. Animal Models in Preclinical Studies:
    There is a decline in the use of animal models for preclinical studies in favor of more human-relevant models or in vitro systems, indicating a shift towards ethical considerations and advancements in alternative research methodologies.

Similar Journals

FEBS Open Bio

Championing transparency in the world of molecular science.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

Microbial Cell Factories

Pioneering Research in Applied Microbiology and Biotechnology
Publisher: BMCISSN: Frequency: 1 issue/year

Microbial Cell Factories is a premier peer-reviewed journal dedicated to the field of applied microbiology and biotechnology, published by BMC in the United Kingdom since 2002. With an impressive impact factor, this journal has consistently ranked within the Q1 category across multiple disciplines, including Applied Microbiology, Bioengineering, and Biotechnology, showcasing its significance in the scientific community. The journal’s commitment to open access ensures that innovative research is freely available to researchers, professionals, and students worldwide, fostering collaboration and knowledge dissemination. With a strong presence in Scopus rankings, Microbial Cell Factories is recognized for its contributions to advancing the understanding and application of microbial processes in production systems, making it an essential resource for those involved in the microbiological and biotechnological fields.

Biotechnology Journal

Exploring the nexus of microbiology and molecular medicine.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-6768Frequency: 12 issues/year

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Unraveling Complexities in Molecular Biology
Publisher: BEGELL HOUSE INCISSN: 1045-4403Frequency: 3 issues/year

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, published by BEGELL HOUSE INC, serves as a vital resource within the fields of Genetics and Molecular Biology. With the ISSN 1045-4403 and E-ISSN 2162-6502, this journal has been contributing to scientific discourse since 1990 and is projected to continue its publication until 2024. Despite its classification in the Q3 quartile for both Genetics and Molecular Biology, its impact on the research community is significant, as evidenced by its diverse range of critical reviews that synthesize and analyze emerging trends and foundational studies in gene expression. The journal, located in the United States at 50 North St, Danbury, CT 06810, offers a platform for researchers, professionals, and students to engage with innovative ideas and methodologies that drive forward the understanding of gene regulatory mechanisms in eukaryotes. Although it currently does not offer open access, the journal's content remains crucial for those dedicated to advancing knowledge in the intricacies of genetic expression.

Acta Naturae

Exploring the Depths of Molecular Biology and Medicine
Publisher: RUSSIAN FEDERATION AGENCY SCIENCE & INNOVATIONISSN: 2075-8251Frequency: 4 issues/year

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

Frontiers in Bioscience-Landmark

Driving Impactful Research in the Biosciences
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

ELECTRONIC JOURNAL OF BIOTECHNOLOGY

Fostering Innovative Research for Global Impact
Publisher: PONTIFICIA UNIV CATOLICA VALPARAISOISSN: 0717-3458Frequency: 6 issues/year

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

JOURNAL OF BIOSCIENCES

Championing Impactful Discoveries in Life Sciences
Publisher: INDIAN ACAD SCIENCESISSN: 0250-5991Frequency: 1 issue/year

JOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.

Biomolecules

Exploring the intricate world of proteins, nucleic acids, and carbohydrates.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

ACTA BIOCHIMICA POLONICA

Shaping the Future of Biochemistry with Every Publication
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.